Cell-mediated immune response to Coxiella burnetii antigens in Q fever convalescents and vaccinees
- PMID: 2576587
Cell-mediated immune response to Coxiella burnetii antigens in Q fever convalescents and vaccinees
Abstract
Cellular immunity against phase I and II Coxiella burnetii antigens was evaluated by the lymphocyte blast transformation test in a) Q fever convalescents; b) persons immunized with a chemovaccine against Q fever; and c) control persons. The first two groups consisted of workers in a ricketsiology department. Of the 9 convalescents, all (100%) were positive against phase I antigen and 4 (44.4%) against phase II antigen. Of the 22 vaccinees, 77.3% were positive against phase I antigen and all were negative against phase II antigen. All 10 controls were negative against both antigens.
Similar articles
-
The value of skin test in Q fever convalescents and vaccinees as indicator of antigen exposure and inducer of antibody recall.Acta Virol. 1984 Mar;28(2):134-40. Acta Virol. 1984. PMID: 6145346
-
Immunity in Q fever.Acta Virol. 1988 Jul;32(4):358-68. Acta Virol. 1988. PMID: 2903642 Review.
-
Coxiella burnetii antigens for detection of Q fever antibodies by ELISA in human sera.Acta Virol. 1987 May;31(3):254-9. Acta Virol. 1987. PMID: 2888290
-
Effect of lysozyme on the immune response of guinea pigs to the soluble phase 1 antigen of Coxiella burnetii.Acta Virol. 1981 Jul;25(4):241-4. Acta Virol. 1981. PMID: 6116419 No abstract available.
-
Vaccines against Coxiella infection.Expert Rev Vaccines. 2004 Oct;3(5):577-84. doi: 10.1586/14760584.3.5.577. Expert Rev Vaccines. 2004. PMID: 15485337 Review.
Cited by
-
Characterization and protective effect of a 29 kDa protein isolated from Coxiella burnetii by detergent Empigen BB.Eur J Epidemiol. 1994 Apr;10(2):227-30. doi: 10.1007/BF01730376. Eur J Epidemiol. 1994. PMID: 7813704
-
Variation in interferon-gamma responses to Coxiella burnetii antigens with lymphocytes from vaccinated or naturally infected subjects.Clin Exp Immunol. 1993 Dec;94(3):507-15. doi: 10.1111/j.1365-2249.1993.tb08226.x. Clin Exp Immunol. 1993. PMID: 8252811 Free PMC article.
-
An O-Specific Polysaccharide/Tetanus Toxoid Conjugate Vaccine Induces Protection in Guinea Pigs against Virulent Challenge with Coxiella burnetii.Vaccines (Basel). 2022 Aug 25;10(9):1393. doi: 10.3390/vaccines10091393. Vaccines (Basel). 2022. PMID: 36146471 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Research Materials